🔎 Trials Near Me

Pradžia › Geltonosios dėmės degeneracija › Masčusetsas

Geltonosios dėmės degeneracija klinikiniai tyrimai Masčusetsas

14 tyrimai dėl Geltonosios dėmės degeneracija ieško dalyvių vietose Masčusetsas.

Miestai Masčusetsas

Oficialus tyrimo tekstas (anglų kalba)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Ophthalmic Consultants of Boston, Boston
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148

A Study in Adults With Geographic Atrophy

  • Ophthalmic Consultants of Boston, Waltham
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Massachusetts Eye And Ear Infirmary, Boston
  • Opthalmic Consultants of Boston, Boston
  • New England Retina Consultants, PC, Springfield
  • ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Retina Research Institute at New England Retina Consultants, Springfield
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Ophthalmic Consultants of Boston, Boston
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT03178149

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

  • Ophthalmic Consultants of Boston, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT06346600

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center, Boston
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Retina Research Institute at New England Retina Consultants, PC, Springfield
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07496567

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

  • Ophthalmic Consultants of Boston, East Weymouth
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07230834

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

  • MCPHS 10 Lincoln Square, Worcester
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius nuo 50 iki 100 · Visoms lytims · Atnaujinta 2026-05-12 · NCT06593405

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

  • New England College of Optometry, Boston
Renkami dalyviai
Amžius 14 ir vyresni · Visoms lytims · Atnaujinta 2026-05-11 · NCT07577219

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • New England Retina Consultants, Springfield
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT07064759

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

  • Massachusetts Eye and Ear Infirmary, Boston
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-01-26 · NCT04735263

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Tallman Eye Associates, Lawrence
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2024-12-03 · NCT05438732

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.